Dodick DW - Search Results

1

Patient-Centered Treatment of Chronic Migraine With Medication Overuse: A Prospective, Randomized, Pragmatic Clinical Trial.

Schwedt TJ, Hentz JG, Sahai-Srivastava S, Murinova N, Spare NM, Treppendahl C, Martin VT, Birlea M, Digre K, Watson D, Leonard M, Robert T, Dodick DW; MOTS Investigators. Schwedt TJ, et al. Among authors: dodick dw. Neurology. 2022 Apr 5;98(14):e1409-e1421. doi: 10.1212/WNL.0000000000200117. Epub 2022 Feb 15. Neurology. 2022. PMID: 35169011 Clinical Trial.

2

Botulinum neurotoxin for the treatment of migraine and other primary headache disorders: from bench to bedside.

Dodick DW. Dodick DW. Headache. 2003 Jul-Aug;43 Suppl 1:S25-33. doi: 10.1046/j.1526-4610.43.7s.5.x. Headache. 2003. PMID: 12887391 Review.

3

Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine.

Dodick D, Lipton RB, Martin V, Papademetriou V, Rosamond W, MaassenVanDenBrink A, Loutfi H, Welch KM, Goadsby PJ, Hahn S, Hutchinson S, Matchar D, Silberstein S, Smith TR, Purdy RA, Saiers J; Triptan Cardiovascular Safety Expert Panel. Dodick D, et al. Headache. 2004 May;44(5):414-25. doi: 10.1111/j.1526-4610.2004.04078.x. Headache. 2004. PMID: 15147249 Review.

4

Cardiovascular tolerability and safety of triptans: a review of clinical data.

Dodick DW, Martin VT, Smith T, Silberstein S. Dodick DW, et al. Headache. 2004 May;44 Suppl 1:S20-30. doi: 10.1111/j.1526-4610.2004.04105.x. Headache. 2004. PMID: 15149490 Review.

5

Botulinum neurotoxin for the treatment of migraine and other primary headache disorders.

Dodick D, Blumenfeld A, Silberstein SD. Dodick D, et al. Clin Dermatol. 2004 Jan-Feb;22(1):76-81. doi: 10.1016/j.clindermatol.2003.12.031. Clin Dermatol. 2004. PMID: 15158549 Review.

6

Duration of migraine is a predictor for response to botulinum toxin type A.

Eross EJ, Gladstone JP, Lewis S, Rogers R, Dodick DW. Eross EJ, et al. Among authors: dodick dw. Headache. 2005 Apr;45(4):308-14. doi: 10.1111/j.1526-4610.2005.05067.x. Headache. 2005. PMID: 15836566 Clinical Trial.

7

Third gene identified for hereditary headache.

Schwedt TJ, Dodick DW. Schwedt TJ, et al. Among authors: dodick dw. Lancet Neurol. 2005 Sep;4(9):519-20. doi: 10.1016/S1474-4422(05)70149-6. Lancet Neurol. 2005. PMID: 16109357 No abstract available.

8

Oral sumatriptan for the acute treatment of probable migraine: first randomized, controlled study.

Tepper SJ, Cady R, Dodick D, Freitag FG, Hutchinson SL, Twomey C, Kuhn TA. Tepper SJ, et al. Headache. 2006 Jan;46(1):115-24. doi: 10.1111/j.1526-4610.2006.00300.x. Headache. 2006. PMID: 16412159 Clinical Trial.

9

Thunderclap stroke: embolic cerebellar infarcts presenting as thunderclap headache.

Schwedt TJ, Dodick DW. Schwedt TJ, et al. Among authors: dodick dw. Headache. 2006 Mar;46(3):520-2. doi: 10.1111/j.1526-4610.2006.00386_3.x. Headache. 2006. PMID: 16618276

10

Pathophysiology and management of transformed migraine and medication overuse headache.

Boes CJ, Black DF, Dodick DW. Boes CJ, et al. Among authors: dodick dw. Semin Neurol. 2006 Apr;26(2):232-41. doi: 10.1055/s-2006-939924. Semin Neurol. 2006. PMID: 16628534 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters